Steel Grove Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.72M | Buy |
71,307
+1,085
| +2% | +$28.4K | 0.16% | 78 |
|
|
2026
Q1 | $1.97M | Buy |
70,222
+6,107
| +10% | +$163K | 0.21% | 52 |
|
|
2025
Q4 | $1.6M | Sell |
64,115
-7,973
| -11% | -$201K | 0.17% | 68 |
|
|
2025
Q3 | $1.75M | Hold |
72,088
| – | – | 0.21% | 70 |
|
|
2025
Q2 | $1.75M | Buy |
72,088
+3,266
| +5% | +$76.2K | 0.21% | 70 |
|
|
2025
Q1 | $1.74M | Buy |
68,822
+56,033
| +438% | +$1.47M | 0.26% | 54 |
|
|
2024
Q4 | $339K | Sell |
12,789
-44,678
| -78% | -$1.21M | 0.05% | 134 |
|
|
2024
Q3 | $1.67M | Sell |
57,467
-1,187
| -2% | -$34.6K | 0.23% | 66 |
|
|
2024
Q2 | $1.64M | Sell |
58,654
-1,930
| -3% | -$53.1K | 0.23% | 65 |
|
|
2024
Q1 | $1.68M | Buy |
60,584
+45,604
| +304% | +$1.27M | 0.22% | 71 |
|
|
2023
Q4 | $431K | Sell |
14,980
-45,907
| -75% | -$1.39M | 0.06% | 108 |
|
|
2023
Q3 | $2.02M | Buy |
60,887
+4,538
| +8% | +$160K | 0.27% | 49 |
|
|
2023
Q2 | $2.07M | Buy |
56,349
+9,118
| +19% | +$355K | 0.26% | 52 |
|
|
2023
Q1 | $1.93M | Buy |
47,231
+2,415
| +5% | +$104K | 0.26% | 63 |
|
|
2022
Q4 | $2.3M | Buy |
44,816
+1,863
| +4% | +$89.3K | 0.33% | 42 |
|
|
2022
Q3 | $1.88M | Buy |
42,953
+2,248
| +6% | +$109K | 0.33% | 39 |
|
|
2022
Q2 | $2.13M | Buy |
40,705
+1,297
| +3% | +$66.1K | 0.39% | 27 |
|
|
2022
Q1 | $2.04M | Sell |
39,408
-10,305
| -21% | -$535K | 0.32% | 35 |
|
|
2021
Q4 | $2.94M | Sell |
49,713
-769
| -2% | -$38.1K | 0.58% | 19 |
|
|
2021
Q3 | $2.17M | Buy |
50,482
+2,245
| +5% | +$99.5K | 0.49% | 21 |
|
|
2021
Q2 | $1.89M | Buy |
48,237
+9,998
| +26% | +$389K | 0.52% | 29 |
|
|
2021
Q1 | $1.39M | Buy |
38,239
+1,837
| +5% | +$65.2K | 0.45% | 53 |
|
|
2020
Q4 | $1.34M | Sell |
36,402
-1,757
| -5% | -$64.4K | 0.44% | 46 |
|
|
2020
Q3 | $1.33M | Sell |
38,159
-1,210
| -3% | -$42.4K | 0.54% | 40 |
|
|
2020
Q2 | $1.22M | Sell |
39,369
-5,410
| -12% | -$184K | 0.55% | 45 |
|
|
2020
Q1 | $1.39M | Buy |
44,779
+819
| +2% | +$27.9K | 0.91% | 21 |
|
|
2019
Q4 | $1.63M | Buy |
43,960
+5,329
| +14% | +$190K | 0.91% | 30 |
|
|
2019
Q3 | $1.32M | Buy |
38,631
+1,046
| +3% | +$38K | 0.78% | 50 |
|
|
2019
Q2 | $1.54M | Buy |
37,585
+1,221
| +3% | +$48.5K | 0.96% | 27 |
|
|
2019
Q1 | $1.47M | Sell |
36,364
-146,475
| -80% | -$5.87M | 0.95% | 31 |
|
|
2018
Q4 | $7.57M | Sell |
182,839
-35,295
| -16% | -$1.47M | 1.07% | 23 |
|
|
2018
Q3 | $9.12M | Buy |
218,134
+21,652
| +11% | +$834K | 1.27% | 13 |
|
|
2018
Q2 | $6.76M | Buy |
196,482
+144,425
| +277% | +$4.94M | 1.09% | 26 |
|
|
2018
Q1 | $1.75M | Sell |
52,057
-1,671
| -3% | -$57.4K | 0.27% | 84 |
|
|
2017
Q4 | $1.85M | Sell |
53,728
-1,769
| -3% | -$60.3K | 0.28% | 82 |
|
|
2017
Q3 | $1.88M | Buy |
55,497
+45,231
| +441% | +$1.45M | 0.34% | 69 |
|
|
2017
Q2 | $327K | Sell |
10,266
-1,037
| -9% | -$32.7K | 0.06% | 222 |
|
|
2017
Q1 | $367K | Sell |
11,303
-127,067
| -92% | -$4.01M | 0.06% | 204 |
|
|
2016
Q4 | $4.26M | Sell |
138,370
-352
| -0.3% | -$10.7K | 0.85% | 49 |
|
|
2016
Q3 | $4.46M | Buy |
138,722
+5,282
| +4% | +$177K | 1.01% | 31 |
|
|
2016
Q2 | $4.46M | Buy |
133,440
+5,172
| +4% | +$165K | 1.1% | 25 |
|
|
2016
Q1 | $3.61M | Sell |
128,268
-10,761
| -8% | -$307K | 0.92% | 46 |
|
|
2015
Q4 | $4.26M | Sell |
139,029
-4,749
| -3% | -$149K | 1.05% | 28 |
|
|
2015
Q3 | $4.29M | Sell |
143,778
-23,587
| -14% | -$756K | 1.07% | 28 |
|
|
2015
Q2 | $5.32M | Sell |
167,365
-1,525
| -0.9% | -$49.7K | 1.18% | 27 |
|
|
2015
Q1 | $5.58M | Buy |
+168,890
| New | +$5.37M | 1.25% | 27 |
|
|
2014
Q3 | $4.1M | Buy |
146,178
+7,741
| +6% | +$217K | 0.96% | 51 |
|
|
2014
Q2 | $3.9M | Buy |
138,437
+435
| +0.3% | +$12.4K | 0.92% | 51 |
|
|
2014
Q1 | $4.21M | Buy |
138,002
+14,966
| +12% | +$446K | 1.04% | 34 |
|
|
2013
Q4 | $3.58M | Buy |
123,036
+13,006
| +12% | +$379K | 0.9% | 39 |
|
|
2013
Q3 | $3M | Buy |
110,030
+2,660
| +2% | +$72.4K | 0.85% | 38 |
|
|
2013
Q2 | $2.85M | Buy |
+107,370
| New | +$2.97M | 0.91% | 34 |
|
Other funds holding PFE
Steel Grove Capital Advisors's PFE Position: Q2 2026 in Review
Steel Grove Capital Advisors increased its Pfizer (PFE) stake by 1.5% in Q2 2026, buying an estimated $28.4K and bringing the position to 71,307 shares worth $1.72M. The position accounts for 0.16% of the portfolio, ranked #78.
Steel Grove Capital Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.12M in Q3 2018. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Steel Grove Capital Advisors held 71,307 shares of Pfizer worth $1.72M as of Q2 2026.
- Steel Grove Capital Advisors bought 1,085 Pfizer shares in Q2 2026, an estimated $28.4K.
- Pfizer made up 0.16% of Steel Grove Capital Advisors's portfolio in Q2 2026, its #78 holding.
- Steel Grove Capital Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Steel Grove Capital Advisors's Pfizer position peaked at $9.12M in Q3 2018.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Steel Grove Capital Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.